HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

In vitro cell growth inhibition by metallocene dichlorides.

Abstract
The in vitro growth-inhibiting potencies of titanocene dichloride (TDC), zirconocene dichloride (ZDC), hafnocene dichloride (HDC), vanadocene dichloride (VDC), and molybdocene dichloride (MDC) against Ehrlich ascites tumor (EAT) cells cultured in viro as permanently growing suspension cultures were determined. The most striking growth-suppression activity was detected for VDC. A VDC concentration as low as 5. 10(-6) mol/l effects a highly significant diminution of cell proliferation. TDC and MDC inhibit cellular growth only concentration of 5 . 10(-4) or 10(-3) mol/l, respectively, whereas ZDC and HDC, which are ineffective against EAT cells in vivo, require higher concentration levels. The growth inhibition is caused by a cytotoxic action of the metallocene dichlorides, as is demonstrated in the case of VDC and TDC by differentiation of live and dead EAT cells by means of the dye lissamine green.
AuthorsP Köpf-Maier, W Wagner, H Köpf
JournalCancer chemotherapy and pharmacology (Cancer Chemother Pharmacol) Vol. 5 Issue 4 Pg. 237-41 ( 1981) ISSN: 0344-5704 [Print] GERMANY, WEST
PMID7261252 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents
  • Organometallic Compounds
  • Vanadium Compounds
  • Vanadium
  • vanadocene dichloride
  • hafnocene dichloride
  • molybdocene dichloride
  • Zirconocene dichloride
  • Molybdenum
  • Zirconium
  • Titanium
  • titanocene dichloride
  • Hafnium
Topics
  • Animals
  • Antineoplastic Agents (pharmacology)
  • Carcinoma, Ehrlich Tumor (pathology)
  • Cell Division (drug effects)
  • Cells, Cultured
  • Depression, Chemical
  • Female
  • Hafnium (pharmacology)
  • Mice
  • Molybdenum (pharmacology)
  • Organometallic Compounds (pharmacology)
  • Time Factors
  • Titanium (pharmacology)
  • Vanadium (pharmacology)
  • Vanadium Compounds
  • Zirconium (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: